BNET Industries
Last Fiscal Year Sales:$864.9M
- Private
- UK
Dow Jones Description
Provider of Logistics & Supply Chain Management Services to Oil & Gas Exploration & Production Companies
CEO
Billy AllanNumber of Employees 1,620
Peer Companies
NAICS Code Administrative Management and General Management Consulting Services: 541611
News & Analysis
Filter by
asco plc. and bristol-myers squibb co. - All News and Analysis
ERBITUX -Cetuximab- Scientific Data in Several Tumor Types Presented at ASCO Annual Meeting; Abstracts 3508, 3535, 5533 and 5047
- 2005-05-16
ORLANDO, Fla. -- ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of several clinical studies of ERBITUXR Cetuximab, an IgG1 monoclonal antibody, presented at the American Society of Clinical Oncology ASCO 41st Annual Meeting. Data were presented from clinical studies exploring treatment...
Scientific Data Presented at ASCO Annual Meeting Evaluating ERBITUX-TM- -Cetuximab- in Head and Neck Cancer
- 2004-06-08
Business Editors/Health/Medical Writers NEW ORLEANS--BUSINESS WIRE--June 8, 2004 ImClone Systems Incorporated (Nasdaq: IMCL), Merck KGaA, Darmstadt, Germany (Frankfurt Stock Exchange: MRK), and Bristol-Myers Squibb Company (NYSE: BMY) today announced the findings of two Merck KGaA-sponsored studies of ERBITUXTM Cetuximab Injection, an IgG1 monoclonal antibody, in patients with advanced...
Scientific Data Presented at ASCO Annual Meeting Evaluating ERBITUX-TM- -Cetuximab- in Advanced Non-Small-Cell Lung Cancer
- 2004-06-07
Business Editors/Health/Medical Writers NEW ORLEANS--BUSINESS WIRE--June 7, 2004 ImClone Systems Incorporated (Nasdaq: IMCL), Merck KGaA, Darmstadt, Germany (Frankfurt Stock Exchange: MRK), and Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of two clinical studies of ERBITUXTM Cetuximab Injection, an IgG1 monoclonal antibody, in combination with standard chemotherapy...
Scientific Data Presented at ASCO Annual Meeting Evaluating ERBITUX -TM- -Cetuximab- in Colorectal Cancer
- 2004-06-06
Business Editors/Health/Medical Writers 40th Annual Meeting of American Society of Clinical Oncology NEW ORLEANS--BUSINESS WIRE--June 6, 2004 ImClone Systems Incorporated (Nasdaq: IMCL), Merck KGaA, Darmstadt, Germany (Frankfurt Stock Exchange: MRK), and Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of four clinical studies of ERBITUXTM Cetuximab...
Phase III Study of ERBITUX -TM- -Cetuximab- and High-Dose Radiation in Locally Advanced Head and Neck Cancer Presented at ASCO
- 2004-06-05
Business Editors/Health/Medical Writers 40th Annual Meeting of American Society of Clinical Oncology NEW ORLEANS--BUSINESS WIRE--June 5, 2004 ImClone Systems Incorporated (Nasdaq:IMCL), Merck KGaA, Darmstadt, Germany (Frankfurt Stock Exchange:MRK), and Bristol-Myers Squibb Company (NYSE:BMY) today announced the results of an international, randomized phase III study of 424 patients...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Billy Allan | CEO |
| Bill Loch | Director, Strategic Dev |
| Derek Smith | Director, Operations |
| Ian Ross | Director, Finance |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Mike Salter | Chairman |
| Hugh Lenon | Board of Directors |
| Jim Cooper | Board of Directors |
| Richard Daw | Board of Directors |
| Rodney Lenthall | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Director, Strategic Dev | Current |
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Director, Operations | Current |
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Accenture Ltd. F1Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about ACN
-
FedEx F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about FDX
-
Fifth Street Finance Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 10, 2009about FSC
-
SAIC, Inc. F3Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about SAI
-
Casella Waste Systems Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 03, 2009about CWST
Glass Door
ASCO (United Kingdom)
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- E-Book Publisher Smashwords Partners with Barnes & Noble 6 votes
Presented by American Express